Hims & Hers Shares Face Dual Pressure from Security Breach and Insider Sales
08.04.2026 - 04:35:55 | boerse-global.de
Shares of telehealth company Hims & Hers experienced notable selling pressure on April 7, closing down 5.3% at $19.54. The decline followed the simultaneous disclosure of a data security incident involving a third-party vendor and a significant stock sale planned by the company's chief financial officer.
CFO Initiates Multi-Million Dollar Stock Disposal Plan
Regulatory filings revealed substantial insider selling activity. According to a Form 144 filing dated April 6, Chief Financial Officer Oluyemi Okupe intends to sell 240,560 shares, a transaction valued at approximately $4.9 million. The sales are being executed through investment bank Goldman Sachs. On the filing date, Okupe already disposed of 3,975 shares at $19.98 each, generating proceeds of nearly $79,500. Following these transactions, the CFO will retain direct ownership of 318,789 company shares. These disposals are part of a pre-arranged 10b5-1 trading plan, which was established in May 2025.
Third-Party Data Breach Linked to Hacking Group
Separately, the company confirmed a data security event. Between February 4 and February 7, 2026, unauthorized parties gained access to a customer support system. The compromised information included customer names and contact details from support tickets. Hims & Hers stated that protected health information, patient records, and doctor-patient communications were not accessed in the breach.
Should investors sell immediately? Or is it worth buying Hims & Hers?
External cybersecurity analysts have associated the incident with the extortion group "ShinyHunters." The analysts suggest the group accessed the Zendesk support system using a compromised Okta single sign-on account. The company is offering affected customers twelve months of complimentary credit monitoring services.
Strong Fundamentals Contrast with Weak Stock Performance
The company's operational performance presents a more positive picture. For the fourth quarter of 2025, Hims & Hers reported earnings per share of $0.08, significantly surpassing analyst consensus estimates of $0.03. Quarterly revenue climbed 28.4% year-over-year to $617.82 million.
Despite these robust financial results, the equity has struggled in the market. The stock currently trades well below its 200-day moving average of $34.54 and has declined roughly 30.8% over the past twelve months. Market experts maintain an average price target of $31.71 alongside a "Hold" rating. This implies substantial potential upside, but analysts indicate a stabilization in the news flow is likely needed first.
Ad
Hims & Hers Stock: New Analysis - 8 April
Fresh Hims & Hers information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
So schätzen die Börsenprofis Hims Aktien ein!
Für. Immer. Kostenlos.

